David H Adams, Bruce J Kinon, Simin Baygani, Brian A Millen, Isabella Velona, Sara Kollack-Walker, David P Walling. BMC Psychiatry 2013
Times Cited: 69
Times Cited: 69
Houman Homayoun, Bita Moghaddam. J Neurosci 2007
Times Cited: 794
Times Cited: 794
List of shared articles
Times cited
Using human brain imaging studies as a guide toward animal models of schizophrenia.
S S Bolkan, F Carvalho Poyraz, C Kellendonk. Neuroscience 2016
S S Bolkan, F Carvalho Poyraz, C Kellendonk. Neuroscience 2016
The glutamate hypothesis: a pathogenic pathway from which pharmacological interventions have emerged.
S R T Veerman, P F J Schulte, L de Haan. Pharmacopsychiatry 2014
S R T Veerman, P F J Schulte, L de Haan. Pharmacopsychiatry 2014
Can N-Methyl-D-Aspartate Receptor Hypofunction in Schizophrenia Be Localized to an Individual Cell Type?
Alexei M Bygrave, Kasyoka Kilonzo, Dimitri M Kullmann, David M Bannerman, Dennis Kätzel. Front Psychiatry 2019
Alexei M Bygrave, Kasyoka Kilonzo, Dimitri M Kullmann, David M Bannerman, Dennis Kätzel. Front Psychiatry 2019
Drug repurposing and emerging adjunctive treatments for schizophrenia.
Jan Malte Bumb, Frank Enning, F Markus Leweke. Expert Opin Pharmacother 2015
Jan Malte Bumb, Frank Enning, F Markus Leweke. Expert Opin Pharmacother 2015
The mGluR2/3 agonist pomaglumetad methionil normalizes aberrant dopamine neuron activity via action in the ventral hippocampus.
Susan F Sonnenschein, Anthony A Grace. Neuropsychopharmacology 2020
Susan F Sonnenschein, Anthony A Grace. Neuropsychopharmacology 2020
Insights on current and novel antipsychotic mechanisms from the MAM model of schizophrenia.
Susan F Sonnenschein, Anthony A Grace. Neuropharmacology 2020
Susan F Sonnenschein, Anthony A Grace. Neuropharmacology 2020
Emerging therapeutic targets for schizophrenia: a framework for novel treatment strategies for psychosis.
Susan F Sonnenschein, A Grace. Expert Opin Ther Targets 2021
Susan F Sonnenschein, A Grace. Expert Opin Ther Targets 2021
The thalamic reticular nucleus: a functional hub for thalamocortical network dysfunction in schizophrenia and a target for drug discovery.
Judith A Pratt, Brian J Morris. J Psychopharmacol 2015
Judith A Pratt, Brian J Morris. J Psychopharmacol 2015
Targeting metabotropic glutamate receptors for novel treatments of schizophrenia.
James Maksymetz, Sean P Moran, P Jeffrey Conn. Mol Brain 2017
James Maksymetz, Sean P Moran, P Jeffrey Conn. Mol Brain 2017
Involvement of glutamatergic and GABAergic transmission in MK-801-increased gamma band oscillation power in rat cortical electroencephalograms.
T Hiyoshi, D Kambe, J Karasawa, S Chaki. Neuroscience 2014
T Hiyoshi, D Kambe, J Karasawa, S Chaki. Neuroscience 2014